There is no fixed washout date. The first period after stopping Depo-Provera most often arrives three to six months after the date the next injection would have been due, and in some patients it takes nine to twelve months or longer. Nothing reliably speeds it up. Medroxyprogesterone acetate (MPA) is a depot formulation, so ovarian suppression continues until circulating drug falls below the level that blocks ovulation, and that clearance varies between individuals.
Why it matters: Patients commonly read the delay as infertility or as a sign that something is wrong, so a clear timeline at the discontinuation visit prevents repeat anxious calls.
The Short Version
- Expect months, not weeks: suppression persists past the 13-week dosing window.
- First bleeds are irregular: spotting, variable flow, and unpredictable intervals for two or three cycles.
- Ovulation can precede bleeding: pregnancy is possible before any period returns.
- Cramping often returns: dysmenorrhea that the injection suppressed can feel worse than remembered.
- Investigate outliers: prolonged or heavy bleeding, severe pain, or amenorrhea beyond twelve months.
Why the First Period After Stopping Depo-Provera Is Not on a Schedule
Depot MPA is injected as a suspension and released slowly from the muscle or subcutaneous tissue. While levels stay high enough, the mid-cycle gonadotropin surge is blocked, ovulation does not occur, and the endometrium stays thin. That is also why amenorrhea is the expected pattern during use rather than a complication: the US prescribing information for the 150 mg/mL intramuscular product reports amenorrhea in roughly 55 percent of users by 12 months and about 68 percent by 24 months.
After the final dose, drug concentrations fall gradually over months. The dosing interval, 13 weeks for the intramuscular presentation and every 12 to 14 weeks for the subcutaneous 104 mg presentation, reflects contraceptive coverage, not the point at which the hormone is gone. Residual suppression beyond that window is normal and expected.
Duration of use is not a dependable predictor of how quickly bleeding resumes. Neither is body weight, injection site, or the number of doses given, and published evidence on these variables is limited. Counsel on the range instead of offering a formula, and document that the range was discussed.
How Long Until Bleeding Returns After the Last Injection
Count from the date the next injection was due, not from the date the patient decided to stop. That single reframing resolves most of the confusion in clinic.
- Weeks 0 to 13: contraceptive effect from the last dose continues; bleeding is uncommon.
- Months 3 to 6: many patients report their first spotting or a light bleed in this window.
- Months 6 to 12: cycles generally become more predictable, though intervals may still vary by a week or more.
- Beyond 12 months: absent bleeding deserves a pregnancy test and a secondary amenorrhea assessment.
For patients planning conception, the labeling data are reassuring and worth quoting directly: among those who discontinued with the intention of becoming pregnant, about 68 percent conceived within 12 months and roughly 83 percent within 15 months of the last injection, with a median of about 10 months and a reported range of 4 to 31 months. The delay is a pharmacologic lag, not a loss of fertility.
What That First Bleed Usually Looks Like
Unpredictable is the honest answer. The earliest bleeding is frequently anovulatory, so flow and timing do not follow the pattern the patient remembers from before the injection. Some see two or three days of brown spotting. Others get a five to eight day bleed that is heavier than their baseline. Cycle length in the first few months can swing from 21 to 45 days or more before settling.
How long the first bleed lasts
Most first bleeds last a few days to about a week. Bleeding that continues past seven or eight days, or that recurs after only a short gap, is worth assessing rather than waiting out, particularly if the patient is symptomatic. Two or three consecutive prolonged bleeds should prompt the same abnormal uterine bleeding pathway used for any other patient.
Why it can be more painful than expected
Depot progestin suppresses dysmenorrhea, and it is often used for that reason in endometriosis and heavy menstrual bleeding. When ovulatory cycles resume, prostaglandin-driven cramping returns with them, and patients who had years of pain-free amenorrhea may experience that as new or worsened pain. Set the expectation in advance.
Severe, one-sided, or progressive pelvic pain is not simply a returning period. Rule out pregnancy and ectopic pregnancy, pelvic infection, and ovarian cyst accident before attributing pain to cycle resumption.
Signs that cycles are restarting
- Cyclical breast tenderness: often the earliest reported change.
- Mid-cycle discomfort: unilateral twinge around presumed ovulation.
- Cervical mucus changes: increasing clear, stretchy discharge.
- Premenstrual symptoms: bloating, mood change, or acne returning on a pattern.
- Spotting that becomes regular: light bleeds spaced at shortening intervals.
These are soft signs. None of them confirms ovulation, and none should be used to date a pregnancy or to replace a test.
Ovulation, Pregnancy Risk, and Bridging Contraception
Ovulation can occur before any bleeding appears, so a patient who has not yet had a period is not protected. Anyone who does not want to conceive needs a method in place from the time the next injection was due. This is the single most clinically consequential point in the whole conversation.
For patients switching methods, US guidance generally supports starting the new method at the time the next injection would have been given, with backup contraception used according to the requirements of the method being started; the CDC’s selected practice recommendations set out the switching and backup intervals in detail, and are worth checking against the specific method chosen (see the CDC selected practice recommendations for contraceptive use).
Pregnancy testing after discontinuation is imperfect because the patient has no reliable last menstrual period to anchor dating. Test when pregnancy is possible and symptoms or amenorrhea raise the question, and repeat rather than rely on a single early negative result.
Heavy, Prolonged, or Painful Bleeding: What to Assess
Start with pregnancy, then quantify the bleed. Ask about pad or tampon changes per hour, clot size, flooding, and overnight protection, then layer on symptoms of anemia such as lightheadedness, breathlessness on exertion, or palpitations. A complete blood count, with ferritin where iron deficiency is suspected, is a reasonable first test in a patient with a heavy or prolonged bleed.
Remember what the injection may have been masking. Fibroids, polyps, adenomyosis, endometriosis, a bleeding disorder, or thyroid disease can all re-emerge once suppression lifts, and the first heavy bleed is sometimes the first presentation. Take a sexual and STI risk history, and include cervical screening status.
Escalate the same way you would for any acute gynecologic bleed. Soaking through a pad or tampon every hour for several consecutive hours, large clots with hemodynamic change, syncope, or severe unilateral pain with a positive or uncertain pregnancy test all warrant same-day assessment or emergency referral, not a routine follow-up slot.
Persistent Amenorrhea: When to Investigate
A pragmatic threshold is no bleeding twelve months after the date the last injection was due, or sooner if the patient is trying to conceive, has other symptoms, or wants answers. The workup is the standard secondary amenorrhea sequence rather than anything specific to the injection.
Begin with a pregnancy test, then consider thyroid function and prolactin. Assess for features of polycystic ovary syndrome, significant weight change, high training load, restrictive eating, or prior intrauterine instrumentation. Gonadotropins and estradiol help where premature ovarian insufficiency is a consideration. Keep in mind that a patient can also have more than one explanation: lingering depot suppression plus an unrelated endocrine cause.
Explain the plan plainly. Most patients who have waited this long want to know whether their fertility is intact, and a stepwise workup with named tests is more reassuring than being told to wait another six months.
Counseling, Documentation, and Supply Notes
The discontinuation visit is a counseling visit, so treat it as one. Record the date and site of the final injection, the lot number and expiry, the due date of the dose that will not be given, the contraception plan, and the expected timeline that was discussed. That record is what makes a later bleeding or amenorrhea assessment interpretable.
Bone health belongs in the same conversation. The product carries a boxed warning that significant loss of bone mineral density can occur with use, that loss is greater with longer duration, and that it may not be fully reversible after discontinuation, which is why labeling advises against use beyond two years unless other methods are inadequate; the current US prescribing information is the reference to quote (FDA prescribing information database). General counseling on calcium, vitamin D, and weight-bearing activity is appropriate; individual assessment stays with the prescribing clinician.
On the stock side, store injectable progestin presentations at controlled room temperature as stated in the labeling in hand, shake the vial or prefilled syringe vigorously before use, and check expiry at the point of administration. Med Wholesale Supplies is a wholesale supplier of aesthetic, orthopedic and medical products to clinics, hospitals and medical professionals, operating since 2013; prescription injectables should always be sourced through licensed channels appropriate to your state and scope.
Discontinuation Visit Checklist
- Anchor the timeline: count from the date the next dose was due.
- State the range: three to six months typical, up to twelve or more possible.
- Confirm the contraception plan: protection in place from the missed-dose date.
- Preview the first bleeds: irregular timing, variable flow, returning cramps.
- Name the red flags: soaking bleeds, syncope, severe or one-sided pain.
- Set a review point: reassess if no bleeding by twelve months.
- Document fully: last dose date, lot, counseling given, follow-up plan.
Used well, that checklist turns a vague question about when bleeding will return into a dated expectation with clear limits. Patients tolerate uncertainty better when the boundaries of normal are named out loud.
This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified clinician or pharmacist about your situation, and seek urgent care or call your local emergency number for severe or worsening symptoms.







